文献速递头颈外科

局部超氧化物歧化酶治疗头颈癌治疗后颈部纤维化

Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
PubMed 文献 · Head Neck · 2018-05-13

本研究为随机前瞻性盲法临床研究,比较局部超氧化物歧化酶(SOD)与安慰剂治疗头颈癌放疗后颈部纤维化的效果。基线及治疗3个月后评估纤维化分级与生活质量,结果显示两组纤维化评分改善程度相当,组间差异无统计学意义。

要点

  • 局部SOD与安慰剂在3个月时纤维化评分改善程度相当,组间差异无统计学意义。
  • 两组均观察到纤维化改善,提示积极物理治疗对治疗后纤维化有益。
  • 局部SOD对头颈癌治疗后颈部纤维化获益可能有限。

核心结论

  • 局部SOD与安慰剂相比,治疗3个月后颈部纤维化评分改善程度相当,组间差异无统计学意义。
  • 两组均显示纤维化改善,本研究印证了积极物理治疗对头颈癌治疗后纤维化的益处。

研究设计与样本

  • 随机前瞻性盲法临床研究,比较局部SOD与安慰剂治疗头颈癌放疗后颈部纤维化。
  • 基线及治疗3个月后获取纤维化分级与生活质量指标。

主要发现

  • 治疗3个月时,两研究组纤维化评分改善程度相当。
  • 组间差异未达统计学显著。

临床怎么用

  • 局部SOD对头颈癌治疗后颈部纤维化获益可能有限,不应替代积极物理治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Topical superoxide dismutase (SOD) has been shown to decrease postradiation fibrosis in some cancers but has not demonstrated an effect in patients with head and neck cancer. The purpose of this study was to determine if topical SOD is an effective treatment for postradiation neck fibrosis. METHODS: This was a randomized prospective blinded clinical study of topical SOD versus placebo for the treatment of neck fibrosis. Measures of fibrosis grade and quality of life were obtained at baseline and after 3 months of treatment. RESULTS: Improvement in fibrosis score was comparable between the 2 study arms at 3 months. CONCLUSION: Both study groups showed improvement but the differences between groups was not statistically significant. Topical SOD likely has limited benefit for posttreatment neck fibrosis but this study confirms other published evidence of benefit from active physical therapy of posttreatment fibrosis in patients with head and neck cancer.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Landeen KC, Spanos WC, Gromer L, et al. Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer. Head Neck. 2018. PMID: 29756397. doi:10.1002/hed.25119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。